Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cell Reports. Medicine|August 5, 2025
Lassa fever in African green monkeys: Clinical disease and fatal outcome are associated with systemic viral dissemination and inflammationRobert W Cross, Abhishek N Prasad, Jacquelyn Turcinovic, et al.
Emerging Microbes & Infections|January 2, 2024
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primatesCourtney Woolsey, Robert W Cross, Abhishek N Prasad, et al.
Cell Reports. Medicine|January 27, 2024
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virusRobert W Cross, Karla A Fenton, Courtney Woolsey, et al.
Nature Medicine|January 13, 2025
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primatesRobert W Cross, Courtney Woolsey, Abhishek N Prasad, et al.
The Journal of Infectious Diseases|August 19, 2023
Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector MeetingArmand Sprecher, Robert Cross, Andrea Marzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2023
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virusRobert W Cross, Megan L Heinrich, Karla A Fenton, et al.
Vaccine|December 29, 2023
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infectionAlbert To, Teri Ann S Wong, Aquena H Ball, et al.
Science Advances|March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infectionCourtney Woolsey, Robert W Cross, Victor C Chu, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Pageof 6